The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 07, 2022

Filed:

Jun. 08, 2021
Applicant:

Imd Natural Solutions Gmbh, Dortmund, DE;

Inventors:

Marc Stadler, Niederkirchen, DE;

Jens Bitzer, Dortmund, DE;

Bärbel Köpcke, Dortmund, DE;

Kathrin Reinhardt, Dortmund, DE;

Jana Moldenhauer, Dortmund, DE;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/16 (2006.01); C07H 15/04 (2006.01); A23B 4/20 (2006.01); A23B 9/26 (2006.01); A23B 5/14 (2006.01); A61K 8/37 (2006.01); C12P 19/44 (2006.01); A61K 8/365 (2006.01); A61Q 17/00 (2006.01); A23B 7/154 (2006.01); A01N 63/30 (2020.01); A61K 8/9728 (2017.01); A23L 2/44 (2006.01); A61K 8/33 (2006.01); A61Q 5/02 (2006.01);
U.S. Cl.
CPC ...
A01N 43/16 (2013.01); A01N 63/30 (2020.01); A23B 4/20 (2013.01); A23B 5/14 (2013.01); A23B 7/154 (2013.01); A23B 9/26 (2013.01); A23L 2/44 (2013.01); A61K 8/33 (2013.01); A61K 8/365 (2013.01); A61K 8/37 (2013.01); A61K 8/9728 (2017.08); A61Q 5/02 (2013.01); A61Q 17/005 (2013.01); C07H 15/04 (2013.01); C12P 19/44 (2013.01);
Abstract

The invention relates to the use of, and methods of use employing, certain glycolipid compounds as defined in detail below and having preservative or antimicrobial properties, novel compounds of the glycolipid class, and related invention embodiments. The compounds have the formula I wherein m is 3 to 5, n is 2 to 5, o is 0 or 1 and p is 3 to 17, with the proviso that the sum m+n+o+p is not less than 14; andR is a carbohydrate moiety bound via one of its carbon atoms to the binding oxygen,and/or a physiologically, especially pharmaceutically or nutraceutically or cosmetically, acceptable salt thereof, or an ester thereof,as such or in the form of a composition,where the compound may be present in open chain form and/or in the form of a lactone (FIG.).


Find Patent Forward Citations

Loading…